Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Madona Azar, Associate Professor of Medicine, UMass Chan Medical School

Diabetes and obesity can damage the liver to the point of failure – but few people know their risk of developing liver disease

Insulin resistance links MASLD to several other metabolic diseases. Kateryna Kon/Science Photo Library via Getty Images

Liver disease is frighteningly common worldwide.

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a buildup of fat in the liver. Formerly known as nonalcoholic fatty liver disease, this condition affects 1 in 4 people worldwide. Among those with type 2 diabetes, insulin resistance, obesity or all three, the prevalence of MASLD increases to 3 in 4 people.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.